Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teba Alnima

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|February 7, 2026
Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetesTeba Alnima, Mark M Smits
Current Opinion in Lipidology|July 31, 2024
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?Teba Alnima, Mark M Smits, Nordin M J Hanssen
Cardiology Research and Practice|July 5, 2012
Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developmentsTeba Alnima, Peter W de Leeuw, Abraham A Kroon
European Journal of Pharmacology|May 20, 2015
Baropacing as a new option for treatment of resistant hypertensionTeba Alnima, Peter W de Leeuw, Abraham A Kroon
Expert Review of Cardiovascular Therapy|July 15, 2014
Baroreflex activation therapy for patients with drug-resistant hypertensionTeba Alnima, Abraham A Kroon, Peter W de Leeuw
Journal of Vascular Surgery Cases and Innovative Techniques|September 29, 2025
Branched endovascular aneurysm repair complicated by disseminated intravascular coagulation while using tocilizumabElla Lubberdink, Saskia E M Schols, Teba Alnima, et al.
Hypertension (Dallas, Tex. : 1979)|April 17, 2013
Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertensionTeba Alnima, Peter W de Leeuw, Frans E S Tan, et al.
Acta Haematologica|May 2, 2022
COVID-19 Coagulopathy: From Pathogenesis to TreatmentTeba Alnima, Mark M G Mulder, Bas C T van Bussel, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2014
Bilateral or unilateral stimulation for baroreflex activation therapyPeter W de Leeuw, Teba Alnima, Eric Lovett, et al.
Respiratory Medicine|October 30, 2021
High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity?Ruth A L Willems, Bart Spaetgens, Lennart H Conemans, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|February 7, 2026
Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetesTeba Alnima, Mark M Smits
Current Opinion in Lipidology|July 31, 2024
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?Teba Alnima, Mark M Smits, Nordin M J Hanssen
Cardiology Research and Practice|July 5, 2012
Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developmentsTeba Alnima, Peter W de Leeuw, Abraham A Kroon
European Journal of Pharmacology|May 20, 2015
Baropacing as a new option for treatment of resistant hypertensionTeba Alnima, Peter W de Leeuw, Abraham A Kroon
Expert Review of Cardiovascular Therapy|July 15, 2014
Baroreflex activation therapy for patients with drug-resistant hypertensionTeba Alnima, Abraham A Kroon, Peter W de Leeuw
Journal of Vascular Surgery Cases and Innovative Techniques|September 29, 2025
Branched endovascular aneurysm repair complicated by disseminated intravascular coagulation while using tocilizumabElla Lubberdink, Saskia E M Schols, Teba Alnima, et al.
Hypertension (Dallas, Tex. : 1979)|April 17, 2013
Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertensionTeba Alnima, Peter W de Leeuw, Frans E S Tan, et al.
Acta Haematologica|May 2, 2022
COVID-19 Coagulopathy: From Pathogenesis to TreatmentTeba Alnima, Mark M G Mulder, Bas C T van Bussel, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2014
Bilateral or unilateral stimulation for baroreflex activation therapyPeter W de Leeuw, Teba Alnima, Eric Lovett, et al.
Respiratory Medicine|October 30, 2021
High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity?Ruth A L Willems, Bart Spaetgens, Lennart H Conemans, et al.
Pageof 2